Search research articles
Contact Us
Filters
Showing results (31-40 of 52) with videos related to
Page
of 6
Sort By:
Cancer Biotherapy & Radiopharmaceuticals
|
September 30, 2010
Renal dosimetry
Barry W Wessels, Roger G Dale, Marta Cremonesi, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 8, 2003
P105 as a prognostic indicator in patients irradiated for locally advanced head-and-neck cancer: a clinical/laboratory correlative analysis of RTOG-9003
E Hammond, Brian A Berkey, Karen K Fu, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 5, 2007
Predictors of distant brain recurrence for patients with newly diagnosed brain metastases treated with stereotactic radiosurgery alone
Stephen M Sawrie, Barton L Guthrie, Sharon A Spencer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 20, 2008
Phase II study of palifermin and concurrent chemoradiation in head and neck squamous cell carcinoma
David M Brizel, Barbara A Murphy, David I Rosenthal, et al.
American Journal of Clinical Oncology
|
December 2, 2016
Safety and Outcome Measures of First-in-Human Intraperitoneal α Radioimmunotherapy With 212Pb-TCMC-Trastuzumab
Ruby F Meredith, Julien J Torgue, Tania A Rozgaja, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 22, 2008
Locoregionally advanced head and neck cancer treated with primary radiotherapy: a comparison of the addition of cetuximab or chemotherapy and the impact of protocol treatment
Jimmy J Caudell, Stephen M Sawrie, Sharon A Spencer, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 19, 2008
Factors associated with long-term dysphagia after definitive radiotherapy for locally advanced head-and-neck cancer
Jimmy J Caudell, Philip E Schaner, Ruby F Meredith, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 6, 2003
Phase III quality-of-life study results: impact on patients' quality of life to reducing xerostomia after radiotherapy for head-and-neck cancer--RTOG 97-09
Jacquelyn Fisher, Charles Scott, Charles W Scarantino, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 4, 2006
166Ho-DOTMP radiation-absorbed dose estimation for skeletal targeted radiotherapy
Hazel B Breitz, Richard E Wendt, Michael S Stabin, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
August 24, 2005
Pretargeted radioimmunotherapy (RIT) with a novel anti-TAG-72 fusion protein
Andres Forero-Torres, Sui Shen, Hazel Breitz, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 52) with videos related to
Sort By:
Page
of 6
Cancer Biotherapy & Radiopharmaceuticals
|
September 30, 2010
Renal dosimetry
Barry W Wessels, Roger G Dale, Marta Cremonesi, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 8, 2003
P105 as a prognostic indicator in patients irradiated for locally advanced head-and-neck cancer: a clinical/laboratory correlative analysis of RTOG-9003
E Hammond, Brian A Berkey, Karen K Fu, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 5, 2007
Predictors of distant brain recurrence for patients with newly diagnosed brain metastases treated with stereotactic radiosurgery alone
Stephen M Sawrie, Barton L Guthrie, Sharon A Spencer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 20, 2008
Phase II study of palifermin and concurrent chemoradiation in head and neck squamous cell carcinoma
David M Brizel, Barbara A Murphy, David I Rosenthal, et al.
American Journal of Clinical Oncology
|
December 2, 2016
Safety and Outcome Measures of First-in-Human Intraperitoneal α Radioimmunotherapy With 212Pb-TCMC-Trastuzumab
Ruby F Meredith, Julien J Torgue, Tania A Rozgaja, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 22, 2008
Locoregionally advanced head and neck cancer treated with primary radiotherapy: a comparison of the addition of cetuximab or chemotherapy and the impact of protocol treatment
Jimmy J Caudell, Stephen M Sawrie, Sharon A Spencer, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 19, 2008
Factors associated with long-term dysphagia after definitive radiotherapy for locally advanced head-and-neck cancer
Jimmy J Caudell, Philip E Schaner, Ruby F Meredith, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 6, 2003
Phase III quality-of-life study results: impact on patients' quality of life to reducing xerostomia after radiotherapy for head-and-neck cancer--RTOG 97-09
Jacquelyn Fisher, Charles Scott, Charles W Scarantino, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 4, 2006
166Ho-DOTMP radiation-absorbed dose estimation for skeletal targeted radiotherapy
Hazel B Breitz, Richard E Wendt, Michael S Stabin, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
August 24, 2005
Pretargeted radioimmunotherapy (RIT) with a novel anti-TAG-72 fusion protein
Andres Forero-Torres, Sui Shen, Hazel Breitz, et al.
Page
of 6